Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Journal of Clinical Pharmacology
Volume66
Issue number5
Pages (from-to)497-502
Number of pages6
ISSN0031-6970
DOIs
Publication statusPublished - 2010
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Pharmacokinetics
  • Drug interaction
  • Aliskiren
  • Rifampicin
  • Multidrug resistance transporter 1 P-glycoprotein
  • P-GLYCOPROTEIN
  • CLINICAL-RELEVANCE
  • AZOLE ANTIFUNGALS
  • ORAL MIDAZOLAM
  • HUMAN-LIVER
  • PHARMACOKINETICS
  • METABOLISM
  • PHARMACODYNAMICS
  • IDENTIFICATION
  • KETOCONAZOLE
  • 312 Clinical medicine

Cite this

@article{802a46424e81490182fe5a8744faccca,
title = "Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren",
keywords = "Pharmacokinetics, Drug interaction, Aliskiren, Rifampicin, Multidrug resistance transporter 1 P-glycoprotein, P-GLYCOPROTEIN, CLINICAL-RELEVANCE, AZOLE ANTIFUNGALS, ORAL MIDAZOLAM, HUMAN-LIVER, PHARMACOKINETICS, METABOLISM, PHARMACODYNAMICS, IDENTIFICATION, KETOCONAZOLE, 312 Clinical medicine",
author = "Tuija Tapaninen and Neuvonen, {Pertti J.} and Niemi, {Mikko Olavi}",
year = "2010",
doi = "10.1007/s00228-010-0796-3",
language = "English",
volume = "66",
pages = "497--502",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Heidelberg",
number = "5",

}

Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren. / Tapaninen, Tuija; Neuvonen, Pertti J.; Niemi, Mikko Olavi.

In: European Journal of Clinical Pharmacology, Vol. 66, No. 5, 2010, p. 497-502.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren

AU - Tapaninen, Tuija

AU - Neuvonen, Pertti J.

AU - Niemi, Mikko Olavi

PY - 2010

Y1 - 2010

KW - Pharmacokinetics

KW - Drug interaction

KW - Aliskiren

KW - Rifampicin

KW - Multidrug resistance transporter 1 P-glycoprotein

KW - P-GLYCOPROTEIN

KW - CLINICAL-RELEVANCE

KW - AZOLE ANTIFUNGALS

KW - ORAL MIDAZOLAM

KW - HUMAN-LIVER

KW - PHARMACOKINETICS

KW - METABOLISM

KW - PHARMACODYNAMICS

KW - IDENTIFICATION

KW - KETOCONAZOLE

KW - 312 Clinical medicine

U2 - 10.1007/s00228-010-0796-3

DO - 10.1007/s00228-010-0796-3

M3 - Article

VL - 66

SP - 497

EP - 502

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 5

ER -